Literature DB >> 8839176

Synthesis of the methyl alpha-glycosides of a di-, tri-, and a tetra-saccharide fragment mimicking the terminus of the O-polysaccharide of Vibrio cholerae O:1, serotype Ogawa.

P Lei1, Y Ogawa, P Kovác.   

Abstract

Methyl 4-(3-deoxy-L-glycero-tetronamido)-4,6-dideoxy-2-O-methyl-alpha-D- mannopyranoside was acetylated, and the fully protected methyl glycoside was treated with dichloromethyl methyl ether-ZnCl2 (DCMME-ZnCl2) reagent to give 3-O-acetyl-4-(2,4-di-O-acetyl-3- deoxy-L-glycero-tetronamido)-4,6-dideoxy-2-O-methyl-alpha-D-mannop yranosyl chloride (3). Condensation of 3 with methyl 3-O-acetyl-4-(2,4-di-O-acetyl-3-deoxy-L-glycero-tetronamido)-4,6- dideoxy-alpha-D-mannopyranoside (4) gave the fully acetylated disaccharide 5, which was deacetylated yielding the methyl alpha-glycoside of title disaccharide. The disaccharide glycosyl donor required for the blockwise synthesis of the title tri- and the tetra-saccharide, 3-O-acetyl-4-(2,4-di-O-acetyl-3-deoxy-L-glycero-tetronamido)-4,6-d ideoxy-2-O- methyl-alpha-D-mannopyranosyl-(1-->2)-3-O-acetyl-4- (2,4-di-O-acetyl-3-deoxy-L-glycero-tetronamido)-4,6-dideoxy-alpha- D- mannopyranosyl chloride (12), was obtained by condensation of 3 with the 1-O-acetyl analog of 4, followed by treatment of the disaccharide formed with DCMME-ZnCl2. The synthesis of the methyl alpha-glycoside of the title trisaccharide involved a condensation of 12 with 4, followed by deacetylation. Similarly, the condensation of 12 with 15, the latter being the analog of 5 having a free HO-2, followed by deacetylation, gave the methyl alpha-glycoside of the title tetrasaccharide. All glycosylation reactions were mediated by silver trifluoromethanesulfonate in the presence of 2,4,6-trimethylpyridine. 4-(3-Deoxy-L-glycero-tetronamido)-4,6-dideoxy-2-O-methyl-alpha,bet a-D- mannopyranose was prepared for the first time. It was characterized by NMR spectroscopy, and via its crystalline per-O-acetyl derivative. It is the saccharide whose alpha-form constitutes the terminal, non-reducing end-group of the O-PS of V. cholerea O:1, serotype Ogawa.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8839176     DOI: 10.1016/0008-6215(95)00331-2

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  5 in total

1.  Crystal structure of an anti-carbohydrate antibody directed against Vibrio cholerae O1 in complex with antigen: molecular basis for serotype specificity.

Authors:  S Villeneuve; H Souchon; M M Riottot; J C Mazie; P Lei; C P Glaudemans; P Kovác; J M Fournier; P M Alzari
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

2.  Enhanced stereoselectivity of alpha-mannosylation under thermodynamic control using trichloroacetimidates.

Authors:  Shu-jie Hou; Pavol Kovác
Journal:  Carbohydr Res       Date:  2010-03-21       Impact factor: 2.104

3.  Positive electrospray ion trap multistage mass spectrometric fragmentation of synthetic analogs of saccharide part of lipopolysaccharides of Vibrio cholerae O:1.

Authors:  Vladimir Kováčik; Slavka Bekešová; Igor Tvaroška; Pavol Kováč
Journal:  J Am Soc Mass Spectrom       Date:  2006-04-05       Impact factor: 3.109

4.  Synthesis of spacer-equipped di-, tri-, and the tetrasaccharide fragments of the deacetylated O-PS1 of Citrobacter gillenii O9a,9b, and a related pentasaccharide.

Authors:  Rina Saksena; Anatoli Chernyak; Pavol Kovác
Journal:  Carbohydr Res       Date:  2008-04-04       Impact factor: 2.104

5.  Synthesis of the dodecasaccharide fragment representing the O-polysaccharide of Vibrio cholerae O:1, serotype Ogawa, bearing an aglycon offering flexibility for chemical linking to proteins.

Authors:  Y Ogawa; P Kovac
Journal:  Glycoconj J       Date:  1997-06       Impact factor: 2.916

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.